Article
miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signaling.
Blood - 11 Apr 2013
Bhagat Tushar D, Zhou Li, Sokol Lubomir, Kessel Rachel, Caceres Gisela, Gundabolu Krishna, Tamari Roni, Gordon Shanisha, Mantzaris Ioannis, Jodlowski Tomasz, Yu Yiting, Jing Xiaohong, Polineni Rahul, Bhatia Kavi, Pellagatti Andrea, Boultwood Jacqueline, Kambhampati Suman, Steidl Ulrich, Stein Cy, Ju Wenjun, Liu Gang, Kenny Paraic, List Alan, Bitzer Markus, Verma Amit
Abstract excerpt
Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis that leads to peripheral cytopenias. We observed that SMAD7, a negative regulator of transforming growth factor-beta (TGF-β) receptor-I kinase, is markedly reduced in MDS and leads to ineffective hematopoiesis by overactivation of TGF-β signaling. To determine the cause of SMAD7 reduction in MDS, we analyzed the 3'UTR of the gene and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
